High Levels of Maternal Serum Human Chorionic Gonadotropin in Down Syndrome Pregnancies: The Possible Role of a Transcription Factor on Chromosome 21

R. Goshen,B. Gonik,I. Ariel,Yael Weiss,N. de‐Groot,A. Hochberg
DOI: https://doi.org/10.1159/000020899
1999-03-25
Fetal Diagnosis and Therapy
Abstract:Increased levels of human chorionic gonadotropin (hCG) are used as markers for Down syndrome (DS) screening of low-risk populations. The pathophysiology for increased hCG levels remains unknown. In general, hCG synthesis is limited by the rate of β-chain formation. In the placenta, 2 of a total of 6 hCG β-genes are expressed. We hypothesized that in DS, a transcriptional factor may upregulate β-chain transcription by interacting with the β5-promoter. Primary cell cultures of skin fibroblasts from both normal and DS midtrimester fetuses were established and transfected with the β5-promoter linked to the chloramphenicol-acetyl-transferase reporter gene. The chloramphenicol-acetyl-transferase activity was measured. Three of six DS-derived cell cultures showed a three-fold increase in acetylation. The increase in hCG promoter activity in DS-derived fibroblasts suggests a possible role for a transcriptional factor located on the human chromosome 21 by either directly or indirectly interacting with the β5-promoter.
What problem does this paper attempt to address?